Tchanque-Fossuo Catherine N, Donneys Alexis, Deshpande Sagar S, Sarhaddi Deniz, Nelson Noah S, Monson Laura A, Dahle Sara E, Goldstein Steve A, Buchman Steven R
Ann Plast Surg. 2018 Feb;80(2):176-180. doi: 10.1097/SAP.0000000000001209.
Using distraction osteogenesis (DO) to regenerate robust endogenous bone could greatly enhance postoncologic reconstruction of head and neck cancer. However, radiation (XRT) corrosive effects still preclude DO's immense potential. We posit that adjunctive pretreatment with the radioprotectant amifostine (AMF) can optimize wound healing and allow for successful DO with quantifiable enhancements in bony union and strength despite previous surgical bed irradiation.
Two groups of murine left hemimandibles were exposed to a human equivalent radiation dosage fractionated over 5 daily doses of 7 Gy. AMF-XRT-DO (n = 30) received AMF before radiation, whereas XRT-DO (n = 22) was untreated. All animals underwent left hemimandibular osteotomy and external fixator placement, followed by distraction to a 5.1-mm gap. Left hemimandibles were harvested and mechanically tested for parameters of strength, yield, and breaking load.
Radiation-related complications such as severe alopecia were significantly increased in XRT-DO compared with the AMF-treated group (P = 0.001), whereas infection and death were comparable (P = 0.318). Upon dissection, bony defects were grossly visible in XRT-DO distraction gap compared with AMF-XRT-DO, which exhibited significantly more complete unions (P = 0.004). Those results were significantly increased in the specimens prophylactically treated with AMF (yield: 39.41 N vs 21.78 N, P = 0.023; breaking load: 61.74 N vs 34.77 N, P = 0.044; respectively).
Our study revealed that AMF enhances biomechanical strength, regeneration, and bony union after radiation in a murine model of DO. The use of prophylactic AMF in combination with DO offers the promise of an alternative reconstructive option for patients afflicted with head and neck cancer.
利用牵张成骨术(DO)再生强健的内生骨可极大地改善头颈癌的肿瘤切除术后重建。然而,放疗(XRT)的腐蚀作用仍然限制了DO的巨大潜力。我们推测,使用放射保护剂氨磷汀(AMF)进行辅助预处理可优化伤口愈合,并使DO成功进行,尽管之前手术床接受过放疗,但骨愈合和强度仍有可量化的提高。
两组小鼠左半下颌骨接受相当于人类剂量的辐射,分5天给予,每天7 Gy。AMF-XRT-DO组(n = 30)在放疗前接受AMF,而XRT-DO组(n = 22)未接受治疗。所有动物均接受左半下颌骨截骨术并放置外固定器,随后牵张至5.1毫米的间隙。收集左半下颌骨并进行力学测试,以测定强度、屈服强度和断裂载荷等参数。
与AMF治疗组相比,XRT-DO组与放疗相关的并发症如严重脱发显著增加(P = 0.001),而感染和死亡情况相当(P = 0.318)。解剖时,与AMF-XRT-DO组相比,XRT-DO组牵张间隙中可见明显的骨缺损,AMF-XRT-DO组的骨愈合明显更完整(P = 0.004)。在预防性使用AMF的标本中,这些结果显著增加(屈服强度:39.41 N对21.78 N,P = 0.023;断裂载荷:61.74 N对34.77 N,P = 0.044)。
我们的研究表明,在小鼠DO模型中,AMF可提高放疗后的生物力学强度、再生能力和骨愈合。预防性使用AMF联合DO为头颈癌患者提供了一种替代性重建选择的希望。